CELLINK to receive €2.5 million grant from EU for the development and commercializing project “TumorPrint “
The project aims to develop and commercialize a Specific Bioprinting platform including, Bioinks, software and hardware specialized for printing of human cancer tumors. The total project budget is €3.5 million, CELLINK will fund €1.0 million and the European Commission €2.5 million.The project spans over 29 months and is coordinated and ran solely by CELLINK. The goal with the project is to offer a high throughput screening platform for pharmaceutical companies enabling them to study cell reaction within cancer tumors when exposed to different compounds. CELLINK has retrieved a LOI from a